Immune-Based Cytokine Signatures of Prolonged Pandemic-Associated Chilblains
Giuseppe Sangiorgio1,2, Grace Chamberlin3,4, Riccardo Castagnoli1
1Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Most pandemic-associated chilblains (PAC) resolve spontaneously, but some patients experience persistent symptoms. Prolonged PAC involves a type II interferon signature, T cell activation, and endothelial issues, suggesting new therapeutic targets.
Area of Science:
- Immunology
- Dermatology
- Infectious Disease Epidemiology
Background:
- Pandemic-associated chilblains (PAC) typically resolve spontaneously.
- A subset of patients experiences persistent or recurrent PAC, necessitating further investigation into underlying mechanisms.
Purpose of the Study:
- To analyze peripheral cytokine profiles in patients with prolonged PAC.
- To elucidate the immunological characteristics differentiating prolonged PAC from acute cases.
- To identify potential therapeutic targets for chronic PAC.
Main Methods:
- Peripheral blood samples were collected from 17 patients with prolonged PAC.
- Cytokine profiles were analyzed using multiplex assays.
- Immune signatures were compared to those of acute PAC.
Main Results:
- Elevated levels of IFN-γ, CXCL10, CX3CL1, IL-16, CCL22, and S100A8 were identified in prolonged PAC.
- Prolonged PAC exhibits a type II interferon-skewed inflammatory signature, distinct from the type I interferon response in acute PAC.
- Evidence of T cell activation and endothelial involvement was observed.
Conclusions:
- Prolonged PAC is associated with a distinct type II interferon-driven inflammatory profile.
- Autoimmune comorbidities in some patients suggest pre-existing immune dysregulation contributes to chronicity.
- JAK inhibition and IFN-γ-directed therapies are potential treatment strategies for prolonged PAC.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
06:03Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
Published on: September 20, 2024
